Brief: Lucy Scientific To Acquire Sana-013 Psychedelic Assets From Drug Developer Wesana Health
21/03/2023 13:07
March 21 (Reuters) - Lucy Scientific Discovery Inc
LSDI.O :
* LUCY SCIENTIFIC TO ACQUIRE SANA-013 PSYCHEDELIC ASSETS
FROM DRUG
DEVELOPER WESANA HEALTH
* LUCY SCIENTIFIC DISCOVERY INC - AGGREGATE CONSIDERATION
COMPRISES 1MLN SHARES OF COMMON STOCK AND $570,000 IN CASH
* LUCY SCIENTIFIC DISCOVERY INC - TRANSACTION IS SUBJECT TO
WESANA'S SHAREHOLDER APPROVAL AND IS EXPECTED TO CLOSE IN Q2
2023
* LUCY SCIENTIFIC DISCOVERY INC - DEAL TO ADD DRUG
DEVELOPMENT
CAPABILITIES TO EXISTING BUSINESS OF PSYCHEDELICS MANUFACTURING
OF CO
* LUCY SCIENTIFIC DISCOVERY - AS RESULT OF ACQUISITION, CO
WILL
ADD DRUG DEVELOPMENT CAPABILITIES TO ITS EXISTING BUSINESS OF
PSYCHEDELICS MANUFACTURING
* LUCY SCIENTIFIC DISCOVERY - AS PART OF DEAL, WESANA'S CEO,
DAN
CARCILLO, WILL JOIN CO'S EXECUTIVE TEAM
Source text for Eikon: ID:nGNX230WgV
Further company coverage: LSDI.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Lucy Scientific Discovery
See all newsBrief: Lucy Scientific Discovery Inc. Receives Nasdaq Notification Of Non-Compliance With Listing Rule 5250(C)(1)
Brief: Lucy Scientific Discovery Terminated Amalgamation Agreement With Bluesky Biologicals on March 5
Brief: Lucy Scientific Discovery Announces 1-For-10 Reverse Stock Split To Regain Compliance With Nasdaq Minimum Bid Requirement
Brief: Lucy Scientific Discovery Got Deficiency Letter From Nasdaq That Co Is Not In Compliance With Requirement To Maintain Minimum Bid Price
Brief: Lucy Scientific Acquires High Times Intellectual Property, Including Existing Licensing Agreements In All-Stock Transaction